Comparing the Incomparable? A Systematic Review of Competing Techniques for Converting Descriptive Measures of Health Status into QALY-Weights
暂无分享,去创建一个
[1] R. Kreienberg,et al. A preference-based index for the SF-12. , 2006, Health economics.
[2] Patrick W. Sullivan,et al. US General Population Preferences in a Nationally Representative Sample , 2009 .
[3] J. Richardson,et al. Cost utility analysis: what should be measured? , 1994, Social science & medicine.
[4] R. Osborne,et al. The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of Health-Related Quality of Life , 1999, Quality of Life Research.
[5] M. Hlatky,et al. Quality of life and time trade-off utility measures in patients with coronary artery disease. , 2003, American heart journal.
[6] A. Kulkarni,et al. Distribution-based and anchor-based approaches provided different interpretability estimates for the Hydrocephalus Outcome Questionnaire. , 2006, Journal of clinical epidemiology.
[7] P. Dolan. Modelling valuations for health states , 1997 .
[8] J. R. Bult,et al. Heterogeneity in the Relationship between the Standard-gamble Utility Measure and Health-status Dimensions , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.
[9] Rob Carter,et al. Assessing Cost-Effectiveness – Mental Health: Introduction to the Study and Methods , 2004 .
[10] N. Sengupta,et al. Mapping the SF-12 to the HUI3 and VAS in a Managed Care Population , 2004, Medical care.
[11] Oliver Rivero-Arias,et al. Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[12] William F Lawrence,et al. Predicting EuroQoL EQ-5D Preference Scores from the SF-12 Health Survey in a Nationally Representative Sample , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.
[13] S. Sullivan,et al. Comparison of Directly Elicited Preferences to Preferences Derived from the SF-36 in Adults with Asthma , 2003, Medical decision making : an international journal of the Society for Medical Decision Making.
[14] J. Brazier,et al. The Estimation of a Preference-Based Measure of Health From the SF-12 , 2004, Medical care.
[15] M. Weinstein,et al. Preference-based measures in economic evaluation in health care. , 2000, Annual review of public health.
[16] N. Sengupta,et al. Evaluating Quality-Adjusted Life Years , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.
[17] Leonie Segal,et al. Can we reduce disease burden from osteoarthritis? , 2004, The Medical journal of Australia.
[18] Graeme Hawthorne,et al. Item-based versus subscale-based mappings from the SF-36 to a preference-based quality of life measure. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[19] R. Osborne,et al. Priority setting in Osteoarthritis , 2004 .
[20] Marthe R. Gold,et al. Mapping the SF-12 to Preference-Based Instruments: Convergent Validity in a Low-Income, Minority Population , 2003, Medical care.
[21] D. Shepard,et al. Changes in Quality of Life for Pregnant Women in Substance User Treatment: Developing a Quality of Life Index for the Addictions , 2005, Substance use & misuse.
[22] S. Gabriel,et al. Health-related Quality of Life in Economic Evaluations for Osteoporosis , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.
[23] Andrew M Jones,et al. Inequalities in self-reported health: validation of a new approach to measurement. , 2003, Journal of health economics.
[24] C. Gross,et al. Estimation and comparison of derived preference scores from the SF-36 in lung transplant patients , 2004, Quality of Life Research.
[25] Application of a disease-specific mapping function to estimate utility gains with effective treatment of schizophrenia , 2005, Health and quality of life outcomes.
[26] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[27] G. Andrews,et al. Using the effect size to model change in preference values from descriptive health status , 2004, Quality of Life Research.
[28] Rob Carter,et al. Cost-Effectiveness of Cognitive Behavioural Therapy and Selective Serotonin Reuptake Inhibitors for Major Depression in Children and Adolescents , 2004, The Australian and New Zealand journal of psychiatry.
[29] John Brazier,et al. A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. , 2003, Health economics.
[30] A. Shmueli,et al. Subjective Health Status and Health Values in the General Population , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.
[31] T. Vos,et al. Cost-Effectiveness of Psychological and Pharmacological Interventions for Generalized Anxiety Disorder and Panic Disorder , 2004, The Australian and New Zealand journal of psychiatry.
[32] J. Brazier,et al. Deriving a preference-based single index from the UK SF-36 Health Survey. , 1998, Journal of clinical epidemiology.
[33] Luis Prieto,et al. Health and Quality of Life Outcomes , 2005 .
[34] J. Brazier,et al. The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.
[35] E. Halpern,et al. Comparison of Preference-Based Utilities of the Short-Form 36 Health Survey and Health Utilities Index before and after Treatment of Patients with Intermittent Claudication , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.
[36] T. Vos,et al. Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorder. , 2004, The Australian and New Zealand journal of psychiatry.
[37] T. Ganiats,et al. Comparison of Measured Utility Scores and Imputed Scores From the SF-36 in Patients With Rheumatoid Arthritis , 2005, Medical care.
[38] T. Tosteson,et al. Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among Spine Patient Outcomes Research Trial (SPORT) participants , 2005, Quality of Life Research.
[39] J. Bosch,et al. The Relationship between Descriptive and Valuational Quality-of-life Measures in Patients with Intermittent Claudication , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.
[40] Mark Sculpher,et al. Estimating utility data from clinical indicators for patients with stable angina , 2005, The European Journal of Health Economics.
[41] D A Revicki,et al. Relationship between health utility and psychometric health status measures. , 1992, Medical care.
[42] R. Deyo,et al. The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain. , 2002, Health economics.
[43] J. Ware. SF-36 health survey: Manual and interpretation guide , 2003 .
[44] T. Vos,et al. Cost-Effectiveness of Dexamphetamine and Methylphenidate for the Treatment of Childhood Attention Deficit Hyperactivity Disorder , 2004 .
[45] M C Weinstein,et al. Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning. , 1996, Medical care.
[46] N. Duan,et al. Can Utility-Weighted Health-Related Quality-of-Life Estimates Capture Health Effects of Quality Improvement for Depression? , 2001, Medical care.
[47] A. Shmueli. The SF-36 Profile and Health-Related Quality of Life: An Interpretative Analysis , 1998, Quality of Life Research.
[48] Haomiao Jia,et al. Mapping the SF-12 to the EuroQol EQ-5D Index in a National US Sample , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.
[49] T. Vos,et al. Assessing cost-effectiveness of drug interventions for schizophrenia. , 2005, The Australian and New Zealand journal of psychiatry.
[50] C. Sherbourne,et al. Estimation of utilities for the effects of depression from the SF-12. , 2000, Medical care.
[51] M Johannesson,et al. The Relationship between Health-state Utilities and the SF-12 in a General Population , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.
[52] M Sculpher,et al. PMH45 MAPPING UTILITY SCORES FROM THE EQ-5D AND SF-6D ONTO THE SCHIZOPHRENIA QUALITY OF LIFE SCALE , 2004 .
[53] P. Mohr,et al. Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores , 2004, Schizophrenia Research.
[54] Ross D Crosby,et al. Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[55] Use of the TTU is questionable , 2004, The Medical journal of Australia.
[56] W F Lawrence,et al. Predicting Quality of Well-being Scores from the SF-36 , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.
[57] Barrett T. Kitch,et al. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model. , 2001, The Journal of allergy and clinical immunology.
[58] Amir Shmueli. The Relationship between the Visual Analog Scale and the SF-36 Scales in the General Population: An Update , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.